PetMed Express, Inc. (PETS) — Financial statements
Income statement, balance sheet, and cash flow for PetMed Express, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 227↓17.2% | 274↑6.8% | 257↓6.2% | 273↓9.9% | 304 | |
| Cost of Revenue | 158↓19.6% | 196↑5.7% | 186↓6.2% | 198↓9.7% | 219 | |
| Gross Profit | 69↓11.0% | 78↑9.4% | 71↓5.7% | 75↓10.6% | 84 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 39↓30.0% | 55↑11.7% | 49↑60.5% | 31↑9.0% | 28 | |
| Selling & Marketing Expenses | 24↓3.0% | 25↑26.2% | 19↑3.3% | 19↓13.1% | 22 | |
| SG&A Expenses | 62↓21.7% | 80↑15.8% | 69↑38.8% | 50↓0.6% | 50 | |
| Other Expenses | 8↑67.5% | 5↑216.8% | -4 | 0.00↓100.0% | 4 | |
| Operating Expenses | 71↓16.5% | 85↑30.9% | 65↑30.3% | 50↓7.7% | 54 | |
| Total Costs & Expenses | 229↓18.7% | 281↑12.4% | 250↑0.9% | 248↓9.3% | 273 | |
| Operating Results | ||||||
| Operating Income | -2↑78.0% | -7↓206.3% | 7↓74.5% | 26↓15.8% | 31 | |
| Depreciation & Amortization | 7↓0.2% | 7↑99.0% | 4↑29.5% | 3↑12.8% | 2 | |
| EBITDA | 7↑756.8% | 0.78↓92.9% | 11↓63.1% | 30↓9.6% | 33 | |
| EBIT | -0.33↑94.7% | -6↓184.3% | 7↓72.5% | 27↓11.3% | 31 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↓100.0% | 0.51↑13.6% | 0.45↑34.3% | 0.34↑137.4% | -0.90 | |
| Interest Income | 0.00↓100.0% | 0.51↑13.6% | 0.45↑34.3% | 0.34↑6.7% | 0.31 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 1 | |
| Non-Operating Income | -1↓74.2% | -0.69↑22.9% | -0.89↑34.3% | -1 | 0.00 | |
| Other Income / Expenses | 0.94↑36.9% | 0.69↓22.9% | 0.89↓34.3% | 1↑224.8% | 0.42 | |
| Income Before Tax | -0.59↑90.6% | -6↓184.3% | 7↓72.5% | 27↓12.5% | 31 | |
| Income Tax Expense | 6↑377.2% | 1↓48.3% | 2↓61.4% | 6↓15.1% | 7 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -6↑16.0% | -7↓245.2% | 5↓75.6% | 21↓11.8% | 24 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -6↑16.0% | -7↓245.2% | 5↓75.6% | 21↓11.8% | 24 | |
| Bottom-Line Net Income | -6↑16.0% | -7↓245.2% | 5↓75.6% | 21↓31.1% | 31 | |
| EPS (Basic) | -0.30↑18.9% | -0.37↓248.0% | 0.25↓76.2% | 1.05↓31.4% | 1.53 | |
| EPS (Diluted) | -0.30↑18.9% | -0.37↓248.0% | 0.25↓76.0% | 1.04↓31.6% | 1.52 | |
| Weighted Average Shares | 21↑1.0% | 20↑0.6% | 20↑0.5% | 20↑0.6% | 20 | |
| Weighted Average Diluted Shares | 21↑1.0% | 20↑0.3% | 20↓0.1% | 20↑1.2% | 20 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.